Colon Cancer

Colonoscopy far more cost-effective than promising Cox II drugs, study predicts

Published in Cancer Weekly, May 27th, 2003

A new study gives Americans over 50 one more reason not to put off having a colonoscopy to check for colon cancer and its forerunners. Not only is the screening technique already known to be very good at finding problems, but new data now show it's far more cost-effective for most people than promising cancer-preventing drugs will probably be.

The new study results come from researchers at the University of California, San Francisco and the University of Michigan Health System. They used a computer model to compare the cost-effectiveness of colonoscopy and other colon cancer screening procedures with that of Cox-II inhibitors, a class of drugs currently used against...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2003-05-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry